PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
04-Sep-2024 PulseSight Therapeutics reinforces its scientific leadership in ophthalmology with the establishment of an International Scientific and Clinical Advisory Board PulseSight Therapeutics SAS
04-Sep-2024 Aixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock Medidata
04-Sep-2024 Prilenia’s Pridopidine for Huntington’s Disease Accepted for European Marketing Authorisation Review Prilenia Therapeutics B.V
04-Sep-2024 GenesisCare UK appoints Second Doctor Director to UK Board GenesisCare UK
04-Sep-2024 QL Biopharm Announces Abstract on Novel Ultra Long-acting GLP-1RA to be Presented at EASD Annual Meeting 2024 QL Biopharm
04-Sep-2024 Expert Speaker Line-Up Revealed for Industry-Leading RBQM Event CluePoints
02-Sep-2024 Theolytics Awarded Significant £2M Transforming Cancer Therapeutics Grant from Innovate UK Theolytics
02-Sep-2024 Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568 Neurocrine Biosciences
02-Sep-2024 EDX MEDICAL ANNOUNCES AGREEMENT WITH CARIS LIFE SCIENCES TO DISTRIBUTE MOLECULAR PROFILING IN THE UNITED KINGDOM AND NORDIC COUNTRIES EDX Medical Group
02-Sep-2024 Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform Medigene AG
02-Sep-2024 New Service Center in Veeva Vault CRM Suite Unifies Sales and Service Veeva Systems
29-Aug-2024 PureTech Health plc – Half-Year Report PureTech
29-Aug-2024 European Commission approves BALVERSA®▼ (erdafitinib) for adult patients with unresectable or metastatic urothelial carcinoma Janssen-Cilag International NV,
29-Aug-2024 European Commission approves RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the treatment of adult patients with advanced EGFR-mutated non-small cell lung cancer after failure of prior therapy Janssen-Cilag International NV
29-Aug-2024 Leqembi® (lecanemab) Authorised for Early Alzheimer’s Disease in Great Britain Eisai Europe, Ltd
27-Aug-2024 BioPhorum acquires training organization Brookwood Global BioPhorum
27-Aug-2024 ENA Respiratory Progresses Phase Ib Study of its Dry Powder Formulation of Intranasal Innate Immunomodulator INNA-051 ENA Respiratory
27-Aug-2024 Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies Microbiotica
27-Aug-2024 Leadership Appointments at RQM+ RQM+
27-Aug-2024 ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse ConTIPI Medical Ltd